1-10 of 10
Fan Zhou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Characteristics and Safety Profile in Patient Received Ixazomib in China: Interim Analysis of a National, Prospective, Non-Interventional Study of Using Ixazomib in Real-World Clinical Practice (INFINITE Study)

Chengcheng Fu, Xin Zhou, Junling Zhuang, Fan Zhou, Yuhua Li, Wenming Chen, Rong Fu, Baijun Fang, Ting Niu, Hao Zhang, Lin Li, Depei Wu
Journal: Blood
Blood (2022) 140 (Supplement 1): 12642–12644.
https://doi.org/10.1182/blood-2022-165127
Published: 2022
Journal Articles

A Simple Risk-Scoring Model for Estimating the Prognostic Impact of 1q Gain in Patients with Newly-Diagnosed Multiple Myeloma

Fengyan Jin, Peiyu Yang, Haimin Chen, Xinyue Liang, Weiling Xu, Shanshan Yu, Wenyang Huang, Xingchen Yi, Qiang Guo, Mengru Tian, Tingting Yue, Mengyao Li, Yingjie Zhang, Mengxue Zhang, Yurong Yan, Zhongli Hu, Shaji K Kumar, Fan Zhou, Yun Dai
Journal: Blood
Blood (2022) 140 (Supplement 1): 4360–4361.
https://doi.org/10.1182/blood-2022-168602
Published: 2022
Journal Articles

Leukemia inhibitory factor protects against graft-versus-host disease while preserving graft-versus-leukemia activity

Jianming Wang, Chun-Yuan Chang, Xue Yang, Fan Zhou, Juan Liu, Sining Zhu, Xue-Zhong Yu, Chen Liu, Timothy E. O’Sullivan, Ping Xie, Zhaohui Feng, Wenwei Hu
Journal: Blood
Blood (2022) 140 (19): 2076–2090.
https://doi.org/10.1182/blood.2022015677
Published: 2022
Includes: Supplemental data
Journal Articles

Macrofocal Multple Myeloma Is a Particular Subgroup of Multiple Myeloma

Jianling Fan, MD, Jian Hou, MD PhD, Juan Du, MD PhD, Lina Jin, Lihui Peng, Baoan Chen, PhD Professor, Hao Xi, Hui Zhang, Hua Jiang, MD, Fan Zhou, Weijun Fu, MD
Journal: Blood
Blood (2015) 126 (23): 1855.
https://doi.org/10.1182/blood.V126.23.1855.1855
Published: 2015
Journal Articles

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

CME
Shimin Hu, Zijun Y. Xu-Monette, Alexander Tzankov, Tina Green, Lin Wu, Aarthi Balasubramanyam, Wei-min Liu, Carlo Visco, Yong Li, Roberto N. Miranda, Santiago Montes-Moreno, Karen Dybkaer, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L. Richards, Eric D. Hsi, William W. L. Choi, Xiaoying Zhao, J. Han van Krieken, Qin Huang, Jooryung Huh, Weiyun Ai, Maurilio Ponzoni, Andrés J. M. Ferreri, Fan Zhou, Graham W. Slack, Randy D. Gascoyne, Meifeng Tu, Daina Variakojis, Weina Chen, Ronald S. Go, Miguel A. Piris, Michael B. Møller, L. Jeffrey Medeiros, Ken H. Young
Journal: Blood
Blood (2013) 121 (20): 4021–4031.
https://doi.org/10.1182/blood-2012-10-460063
Published: 2013
Includes: Supplemental data
Journal Articles

Prognostic Significance and Phenotypic Manifestations of MYC/BCL2 Protein Expression in Diffuse Large B-Cell Lymphoma (DLBCL) with Extranodal Organ Involvement: A Report of the International DLBCL Rituximab-CHOP Consortium Program Study

Anusha Madadi, MD, Meghana Raghavendra, MD, Shimin Hu, Zijun Y. Xu-Monette, PhD, Carlo Visco, MD, Alexander Tzankov, MD, Santiago Montes-Moreno, MD, Karen Dybkaer, April Chiu, MD, Attilio Orazi, MD, Youli Zu, MD, PhD, Govind Bhagat, MD, Cherie H. Dunphy, MD, Eric D. Hsi, MD, Frank X. Zhao, MD, PhD, William W. L. Choi, MD, Xiaoying Zhao, MD, Joannes H.J.M. Van Krieken, PhD, MD, Jooryung Huh, MD, Qin Huang, MD, PhD, Wei Ai, MD, Maurilio Ponzoni, Andrés J.M. Ferreri, MD, Fan Zhou, MD, PhD, Jane N. Winter, MD, Miguel Piris, MD, Michael B. Møller, MD, DMSc, L. Jeffrey Medeiros, MD, Ronald S. Go, MD, Ken H. Young, MD
Journal: Blood
Blood (2012) 120 (21): 544.
https://doi.org/10.1182/blood.V120.21.544.544
Published: 2012
Journal Articles

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

Clinical Trials & Observations
Zijun Y. Xu-Monette, Lin Wu, Carlo Visco, Yu Chuan Tai, Alexander Tzankov, Wei-min Liu, Santiago Montes-Moreno, Karen Dybkær, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L. Richards, Eric D. Hsi, X. Frank Zhao, William W. L. Choi, Xiaoying Zhao, J. Han van Krieken, Qin Huang, Jooryung Huh, Weiyun Ai, Maurilio Ponzoni, Andrés J. M. Ferreri, Fan Zhou, Brad S. Kahl, Jane N. Winter, Wei Xu, Jianyong Li, Ronald S. Go, Yong Li, Miguel A. Piris, Michael B. Møller, Roberto N. Miranda, Lynne V. Abruzzo, L. Jeffrey Medeiros, Ken H. Young
Journal: Blood
Blood (2012) 120 (19): 3986–3996.
https://doi.org/10.1182/blood-2012-05-433334
Published: 2012
Includes: Supplemental data
Journal Articles

The t(14;18)(q32;q21) Characterizes a Subset of Patients with Diffuse Large-B Cell Lymphoma of Germinal Center Origin with Poor Outcome: Report From the International DLBCL Rituximab-CHOP Consortium Program Study

Carlo Visco, MD, Alexander Tzankov, MD, Zijun Y. Xu-Monette, PhD, Roberto N. Miranda, MD, Emanuele S. G. d'Amore, MD, Santiago Montes-Moreno, MD, Karen Dybkaer, PhD, April Chiu, MD, Wayne Tam, MD, PhD, Attilio Orazi, MD, Youli Zu, MD, PhD, Govind Bhagat, MD, Brad S. Kahl, MD, Jane N. Winter, MD, Huan-You Wang, MD, PhD, Cherie H. Dunphy, MD, Eric D. Hsi, MD, Frank X. Zhao, MD, PhD, Ronald S. Go, MD, William W. L. Choi, MD, Fan Zhou, MD, PhD, Magdalena Czader, MD, PhD, Xiaoying Zhao, MD, Joannes H.J.M. Van Krieken, PhD, MD, Qin Huang, MD, PhD, Weiyun Ai, MD, PhD, Joan E. Etzell, MD, Maurilio Ponzoni, MD, Andres J.M. Ferreri, MD, Miguel A. Piris, MD, Michael B. Møller, MD, PhD, Carlos E. Bueso-Ramos, MD, PhD, L. Jeffrey Medeiros, MD, Ken H. Young, MD
Journal: Blood
Blood (2011) 118 (21): 949.
https://doi.org/10.1182/blood.V118.21.949.949
Published: 2011
Journal Articles

Continuous Administration of Low-Dose Cyclophosphamide and Prednisone as a Salvage Treatment for Multiple Myeloma.

Fan Zhou, Lieping Guo, Haotian Shi, Chenhui Lin, Jian Hou
Journal: Blood
Blood (2009) 114 (22): 4962.
https://doi.org/10.1182/blood.V114.22.4962.4962
Published: 2009
Journal Articles

Clinical Impact of TP53 Gene Mutations in Diffuse Large B-Cell Lymphoma (DLBCL): An International DLBCL Rituxan-CHOP Consortium Program Study.

Ken H. Young, MD, PhD, Nancy Patten, PhD, Sim Truong, PhD, Jens Eickhoff, PhD, Gabrielle L. Rocque, MD, Jeffrey T. Malik, MD, Yan Li, PhD, Kazunori Kanehira, MD, PhD, Matthew Twohig, MD, William M. Rehrauer, PhD, Michelle A. Waknitz, MS, Brad S. Kahl, MD, Michael B. Moller, MD, PhD, Alexander Tzankov, PhD, Santiago M. Moreno, MD, Miguel A. Piris, MD, Carlo Visco, MD, Karen Dybkaer, PhD, April Chiu, MD, Attilio Orazi, MD, Jeff C. Chang, MD, PhD, Govind Bhagat, MD, Jane N. Winter, MD, Huan-You Wang, MD, PhD, Cherie Dunphy, MD, Stacey O'Neill, MD, PhD, Eric D. Hsi, MD, Xianfeng Zhao, MD, PhD, Kristin Hunt, MD, Weina Chen, MD, PhD, Ronald S. Go, MD, William W.L. Choi, MD, Fan Zhou, MD, PhD, Magdalena Czader, MD, PhD, Yong Li, PhD, Suzanne Selvaggi, MD, James S. Malter, MD, Lin Wu, PhD
Journal: Blood
Blood (2009) 114 (22): 967.
https://doi.org/10.1182/blood.V114.22.967.967
Published: 2009